Form D — OrbiMed Royalty & Credit Opportunities V, LP
0002041181-25-000001 · filed 2025-05-06
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06b, 3C, 3C.7
- Total offering
- $1,750,000,000
- Total sold
- $1,243,525,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- OrbiMed Royalty & Credit Opportunities V, LP
- CIK
- 2041181
- Entity
- Limited Partnership
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 601 LEXINGTON AVENUE, 54TH FLOOR
NEW YORK, NY 10022 - Phone
- 212-739-6400
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
N/A OrbiMed ROF V, LP · Executive OfficerNew York, NY Find on LinkedIn ↗
-
N/A OrbiMed ROF V LLC · Executive OfficerNew York, NY Find on LinkedIn ↗
-
N/A OrbiMed Advisors LLC · Executive OfficerNew York, NY Find on LinkedIn ↗
-
David P. Bonita · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Sven H. Borho · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Carl L. Gordon · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Geoffrey C. Hsu · Executive OfficerNew York, NY Find on LinkedIn ↗
-
W. Carter Neild · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Matthew S. Rizzo · Executive OfficerNew York, NY Find on LinkedIn ↗
-
C. Scotland Stevens · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Peter A. Thompson · Executive OfficerNew York, NY Find on LinkedIn ↗
View original on SEC EDGAR.